Pulmonary Microbiome May Identify Patients With High-risk Lymphangioleiomyomatosis
Souheil Y. El-Chemaly, MD, and Julie Ng, MD, of Brigham and Women’s Hospital, and colleagues conducted the first study to examine the lung microbiome of patients with lymphangioleiomyomatosis (LAM) who were at high risk of disease progression or death.
Read More...